ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Outcomes in Lung Transplant Recipients Switched from Tacrolimus to Cyclosporine Due to Hyperammonemia Early Post-Transplantation

    S. Goyal, J. Lyons, P. Stracener, B. Bemiss

    Loyola University Medical Center, Chicago, IL

    *Purpose: Assess the impact of switching from tacrolimus to cyclosporine due to hyperammonemia on outcomes at 1-year post-lung transplant.*Methods: A retrospective review of lung transplant…
  • 2022 American Transplant Congress

    Late Liver Turn Downs: The Utilization and Impact of the Expedited Process

    K. Gauntt1, C. Martinez1, R. Hunter1, J. Prinz2, K. Shutterly3, D. Brockmeier4

    1United Network For Organ Sharing, Richmond, VA, 2Donor Alliance, Denver, CO, 3Center for Organ Recovery and Education, Pittsburgh, PA, 4Mid-America Transplant, St. Louis, MO

    *Purpose: There is belief that the discard rates are higher for organs turned down late in the recovery process. The expedited liver (LI) pathway, allows…
  • 2022 American Transplant Congress

    Immunometabolism of Regulatory T Cells Enhanced by Lipid Nanoparticles

    J. S. Rink1, Y. Sambandam2, J. He2, J. Mathew3, J. R. Leventhal4, C. S. Thaxton5

    1Department of Medicine, Division of Hematology/ Oncology, Northwestern University, Chicago, IL, 2Comprehensive Transplant Center, Northwestern University, Chicago, IL, 3Northwestern University, Chicago, IL, 4Surgery, Northwestern Medicine, Chicago, IL, 5Department of Urology, Northwestern University, Chicago, IL

    *Purpose: Human regulatory T cell (Treg) metabolism is highly dependent upon a number of factors, including cholesterol obtained from circulating lipoproteins. We have developed high-density…
  • 2022 American Transplant Congress

    The Role of the Gut Microbiota in Pain Interference Before and After Kidney Transplantation: A Pilot Study

    M. B. Lockwood1, H. DeVon2, M. Maienschein-Cline1, G. Chlipala1, M. Samra3, A. Lichvar4, S. Green5

    1University of Illinois at Chicago, Chicago, IL, 2UCLA, Los Angeles, CA, 3Loyola University Medical Center, Chicago, IL, 4UCSD, San Diego, CA, 5Rush University, Chicago, IL

    *Purpose: To characterize relationships between differential relative abundances of taxonomy (genus level) of the gut microbiome and pain interference before and after living donor kidney…
  • 2022 American Transplant Congress

    Immunoglobulin M (IgM) Inhibits Replication of SARS-CoV-2 In Vero E6 Cells In Vitro and Delays Disease in K18-hACE2 Mice Infected with SARSCoV-2 In Vivo

    P. Chhabra1, B. Mann2, M. Ma1, S. Feldman3, K. L. Brayman1

    1Department of Surgery, University of Virginia Health System, Charlottesville, VA, 2Department of Infectious Diseases, University of Virginia Health System, Charlottesville, VA, 3Center for Comparative Medicine, University of Virginia Health System, Charlottesville, VA

    *Purpose: To determine if IgM has a direct effect in preventing SARS-CoV-2 replication in Vero E6 cells, and delaying or preventing disease in infected K18-hACE2…
  • 2022 American Transplant Congress

    Spectrum of Pre-Transplant Esophagram Abnormalities and Association with Long-Term Outcomes

    I. Lill1, D. Lovin2, A. C. Lawrence2, M. Mohanka2, J. Joerns2, S. Bollineni2, I. L. Timofte2, V. Kaza2, M. Wait3, F. Torres2, A. Banga2

    1University of Texas - Southwestern, Dallas, TX, 2Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Texas - Southwestern, Dallas, TX, 3Cardiovascular & Thoracic Surgery, University of Texas - Southwestern, Dallas, TX

    *Purpose: To determine the frequency and type of esophageal abnormalities on screening esophagram during the pre-transplant evaluation and evaluate the association of these abnormalities on…
  • 2022 American Transplant Congress

    Variability In Plasma Donor-derived Cell-free DNA Levels With CLAD More Than 5-years After Lung Transplantation: Pilot Data

    D. Levine1, D. Ross2

    1Department of Medicine, University of Texas, San Antonio, San Antonio, TX, 2Natera, Inc., Ausin, TX

    *Purpose: Donor-derived cell-free DNA (dd-cfDNA) has been clinically validated for detection of acute rejection (AR) in lung transplant (LT) although studies have typically focused on…
  • 2022 American Transplant Congress

    Predictors Associated with Survival Outcomes for DCD and DBD Renal Transplants from D4 Donors. A Registry Based Machine Learning Analysis (MLA)

    H. Sharma1, A. Sharma2

    1Royal Liverpool University Hospital, Liverpool, United Kingdom, 2Loyola University Chicago, Loyola University Chicago, IL

    *Purpose: Marginal Donor 4- D4 ( Donor Risk Index ≥1.50 ) Matching was introduced as a part of new Kidney allocation scheme in the UK…
  • 2022 American Transplant Congress

    Long-Term Outcomes After Conversion to a Belatacept-Based Immunosuppression in Kidney Transplant: A Matched Cohort Study

    G. Divard, C. Debiais, C. Legendre, O. Aubert, C. Lefaucheur, A. Loupy

    Paris Transplant Group, INSERM, Paris, France

    *Purpose: Conversion to belatacept after transplant seems to be safe. However, no studies have reported the long-term efficacy and safety outcomes after conversion to belatacept…
  • 2022 American Transplant Congress

    Using a Unique Repository of Pancreas Transplant Biopsies to Validate the Tissue Common Response Module (tCRM) Score as a Tool to Assess the Severity of Pancreas Transplant Rejection

    Y. Kelly1, A. Zarinsefat1, R. Meier2, M. Sarwal1, P. Stock1, Z. Laszik1, T. Sigdel1

    1University of California, San Francisco, San Francisco, CA, 2University of Maryland Medical Center, Baltimore, MD

    *Purpose: Analysis of transcriptional data from kidney, heart, liver, and lung transplant rejection led to development of the tissue Common Response Module (tCRM) score based…
  • « Previous Page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • 190
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences